IMAX Zukünftiges Wachstum
Future Kriterienprüfungen 4/6
IMAX wird ein jährliches Gewinn- und Umsatzwachstum von 27.3% bzw. 6.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 27.7% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 20.5% betragen.
Wichtige Informationen
27.2%
Wachstumsrate der Gewinne
27.6%
EPS-Wachstumsrate
Entertainment Gewinnwachstum | 29.3% |
Wachstumsrate der Einnahmen | 6.4% |
Zukünftige Eigenkapitalrendite | 20.1% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 21 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is IMAX (NYSE:IMAX) A Risky Investment?
Jun 19Is It Too Late To Consider Buying IMAX Corporation (NYSE:IMAX)?
May 22IMAX Corporation: Good Reasons To Be Bullish
Apr 08IMAX Corporation Just Recorded A 12% EPS Beat: Here's What Analysts Are Forecasting Next
Mar 01When Should You Buy IMAX Corporation (NYSE:IMAX)?
Feb 15IMAX Corporation: Bull Case Has Merits, But I Am Not Interested
Jan 22IMAX Corporation: International Expansion Remains A Bright Spot
Nov 19Some Investors May Be Worried About IMAX's (NYSE:IMAX) Returns On Capital
Oct 13IMAX Appears Expensive After Post-Pandemic Appreciation
Oct 09IMAX Corporation Stock: Bullish Following A Blockbuster Summer
Aug 24Should You Think About Buying IMAX Corporation (NYSE:IMAX) Now?
Jul 31These Return Metrics Don't Make IMAX (NYSE:IMAX) Look Too Strong
Jul 14IMAX Corporation: Coming Back To Life
Jun 15Are Investors Undervaluing IMAX Corporation (NYSE:IMAX) By 31%?
Jun 07Is It Time To Consider Buying IMAX Corporation (NYSE:IMAX)?
Apr 03IMAX (NYSE:IMAX) Is Carrying A Fair Bit Of Debt
Mar 13IMAX Non-GAAP EPS of $0.19 misses by $0.03, revenue of $98M beats by $1.77M
Feb 22IMAX, Cinema XXI expand relationship with deal for ten new theatres in Indonesia
Feb 14IMAX (NYSE:IMAX) Has Some Difficulty Using Its Capital Effectively
Feb 06IMAX Corporation: All Eyes On China
Jan 30IMAX plans to add seven new locations in Japanese expansion
Jan 19IMAX China gets new key person
Dec 12Is IMAX (NYSE:IMAX) A Risky Investment?
Nov 28IMAX, AMC partner on six new Saudi Arabia theaters
Oct 27Capital Allocation Trends At IMAX (NYSE:IMAX) Aren't Ideal
Oct 17IMAX Corporation: Watch Recent Buyback Program Expansion And Acquisition
Oct 04IMAX acquires streaming technology firm SSIMWAVE in cash-and-stock deal
Sep 22IMAX doubles buyback plan to $400M
Sep 07Cineworld, IMAX enter expanded deal for upgraded and new locations
Aug 03Is IMAX (NYSE:IMAX) Using Too Much Debt?
Jul 28IMAX Is Recovering, Not Growing
Jul 21IMAX extends current share repurchase program
Jun 30IMAX (NYSE:IMAX) Will Be Looking To Turn Around Its Returns
Jun 27IMAX Corporation: Multiple Tailwinds
Jun 21Does IMAX (NYSE:IMAX) Have A Healthy Balance Sheet?
Mar 29IMAX (NYSE:IMAX) Is Finding It Tricky To Allocate Its Capital
Mar 03IMAX: Determining The Future Of 'Bigger Is Better'
Feb 21Is IMAX (NYSE:IMAX) A Risky Investment?
Dec 22IMAX Corporation: Spotlight On IMAX Enhanced And China Market
Nov 19Are Investors Undervaluing IMAX Corporation (NYSE:IMAX) By 45%?
Oct 11IMAX Corporation: The Best Bet In The Industry
Aug 30IMAX (NYSE:IMAX) Is Making Moderate Use Of Debt
Aug 10Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
12/31/2026 | 432 | 57 | 130 | 139 | 5 |
12/31/2025 | 414 | 52 | 49 | 114 | 10 |
12/31/2024 | 380 | 38 | 32 | 84 | 10 |
3/31/2024 | 367 | 26 | -9 | 26 | N/A |
12/31/2023 | 375 | 25 | 26 | 59 | N/A |
9/30/2023 | 387 | 25 | 43 | 71 | N/A |
6/30/2023 | 352 | 4 | 21 | 48 | N/A |
3/31/2023 | 328 | -7 | 11 | 42 | N/A |
12/31/2022 | 301 | -23 | -15 | 17 | N/A |
9/30/2022 | 311 | -15 | -4 | 26 | N/A |
6/30/2022 | 299 | -15 | -7 | 18 | N/A |
3/31/2022 | 276 | -21 | -7 | 13 | N/A |
12/31/2021 | 255 | -22 | -12 | 6 | N/A |
9/30/2021 | 202 | -54 | -25 | -12 | N/A |
6/30/2021 | 183 | -93 | -29 | -19 | N/A |
3/31/2021 | 141 | -109 | -50 | -40 | N/A |
12/31/2020 | 137 | -144 | -32 | -23 | N/A |
9/30/2020 | 205 | -104 | -28 | -8 | N/A |
6/30/2020 | 254 | -48 | -8 | 21 | N/A |
3/31/2020 | 350 | -11 | 56 | 97 | N/A |
12/31/2019 | 396 | 47 | 40 | 90 | N/A |
9/30/2019 | 380 | 30 | 47 | 109 | N/A |
6/30/2019 | 376 | 26 | 46 | 112 | N/A |
3/31/2019 | 370 | 23 | 36 | 94 | N/A |
12/31/2018 | 374 | 23 | 53 | 110 | N/A |
9/30/2018 | 391 | 26 | 41 | 90 | N/A |
6/30/2018 | 408 | 20 | 34 | 95 | N/A |
3/31/2018 | 397 | 11 | 31 | 101 | N/A |
12/31/2017 | 381 | 2 | N/A | 85 | N/A |
9/30/2017 | 362 | 6 | N/A | 96 | N/A |
6/30/2017 | 349 | 10 | N/A | 79 | N/A |
3/31/2017 | 353 | 18 | N/A | 72 | N/A |
12/31/2016 | 376 | 29 | N/A | 78 | N/A |
9/30/2016 | 389 | 42 | N/A | 87 | N/A |
6/30/2016 | 388 | 48 | N/A | 102 | N/A |
3/31/2016 | 404 | 66 | N/A | 83 | N/A |
12/31/2015 | 374 | 55 | N/A | 84 | N/A |
9/30/2015 | 357 | 53 | N/A | 57 | N/A |
6/30/2015 | 332 | 50 | N/A | 70 | N/A |
3/31/2015 | 305 | 39 | N/A | 79 | N/A |
12/31/2014 | 291 | 39 | N/A | 87 | N/A |
9/30/2014 | 293 | 46 | N/A | 94 | N/A |
6/30/2014 | 284 | 43 | N/A | 82 | N/A |
3/31/2014 | 286 | 42 | N/A | 70 | N/A |
12/31/2013 | 288 | 44 | N/A | 55 | N/A |
9/30/2013 | 258 | 30 | N/A | 53 | N/A |
6/30/2013 | 287 | 43 | N/A | 62 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: IMAXDas prognostizierte Gewinnwachstum (27.3% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: IMAXDie Erträge des Unternehmens (27.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: IMAXEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.
Einnahmen vs. Markt: IMAXDie Einnahmen des Unternehmens (6.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: IMAXDie Einnahmen des Unternehmens (6.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: IMAXDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (20.5%)